Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, October 29th:
ConnectOne Bancorp, Inc. (CNOB - Free Report) : This bank holding company has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 2.2% over the last 60 days.
ConnectOne Bancorp’s shares gained 10.5% over the last one month above the S&P 500’s increase 2.1%. The company possesses a Momentum Score of A.
Frontline Ltd. (FRO - Free Report) : This shipping company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing more than 100% over the last 60 days.
Frontline’s shares gained 13.7% over the last one month. The company possesses a Momentum Score of A.
HOYA Corporation (HOCPY - Free Report) : This life care and information technology company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing nearly 3.3% over the last 60 days.
HOYA Corporation’s shares gained 2.8% over the last one month. The company possesses a Momentum Score of A.
M/I Homes, Inc. (MHO - Free Report) : This builder of single-family homes has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 14.6% over the last 60 days.
M/I Homes’ shares gained 16.7% over the last one month. The company possesses a Momentum Score of A.
See the full list of top ranked stocks here
Learn more about the Momentum score and how it is calculated here.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, October 29th:
ConnectOne Bancorp, Inc. (CNOB - Free Report) : This bank holding company has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 2.2% over the last 60 days.
ConnectOne Bancorp’s shares gained 10.5% over the last one month above the S&P 500’s increase 2.1%. The company possesses a Momentum Score of A.
Frontline Ltd. (FRO - Free Report) : This shipping company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing more than 100% over the last 60 days.
Frontline’s shares gained 13.7% over the last one month. The company possesses a Momentum Score of A.
HOYA Corporation (HOCPY - Free Report) : This life care and information technology company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing nearly 3.3% over the last 60 days.
HOYA Corporation’s shares gained 2.8% over the last one month. The company possesses a Momentum Score of A.
M/I Homes, Inc. (MHO - Free Report) : This builder of single-family homes has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 14.6% over the last 60 days.
M/I Homes’ shares gained 16.7% over the last one month. The company possesses a Momentum Score of A.
See the full list of top ranked stocks here
Learn more about the Momentum score and how it is calculated here.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Get the latest research report on FRO - FREE
Get the latest research report on MHO - FREE
Get the latest research report on CNOB - FREE
Get the latest research report on HOCPY - FREE